BU’s Covid tinkering, FDA on trial, & why it’s hard to take drugs off the market
What happens when approved drugs turn out not to work? Is it OK to make SARS-CoV-2 hybrids? And are British tabloids reliable sources of science news?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Lawyer and bioethicist Holly Fernandez Lynch joins us to explain a watershed test of the FDA’s authority to revoke drug approvals. And STAT’s Helen Branswell calls in to discuss the headline-grabbing research at Boston University involving a lab-developed version of the virus that causes Covid-19.
